"Advancing Glioblastoma Treatment with CAR-T and Gene Therapy"

A pioneering clinical trial at UCSF is utilizing a novel CAR-T therapy enhanced by synNotch technology to target glioblastoma, a deadly brain tumor. This advanced approach aims to improve treatment specificity and effectiveness while reducing side effects, potentially extending survival and enhancing patients' quality of life. The trial, funded by grants totaling up to $11 million, represents a significant advancement in translational medicine and offers hope for addressing the urgent need for new treatments for glioblastoma.